Literature DB >> 26667413

Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.

Chiara Lanzani1, Guido Gatti1, Lorena Citterio1, Elisabetta Messaggio1, Simona Delli Carpini1, Marco Simonini1, Nunzia Casamassima1, Laura Zagato1, Elena Brioni1, John M Hamlyn1, Paolo Manunta2.   

Abstract

Circulating levels of endogenous ouabain (EO), a vasopressor hormone of adrenocortical origin, are increased by sodium depletion. Furthermore, lanosterol synthase, an enzyme involved in cholesterol biosynthesis, has a missense polymorphism (rs2254524 V642L) that affects EO biosynthesis in adrenocortical cells. Here, we investigated the hypothesis that lanosterol synthase rs2254524 alleles in vivo impact the blood pressure (BP) and EO responses evoked by a low dietary Na intake (<100 mEq/d, 2 weeks) among patients with mild essential hypertension. During the low salt diet, the declines in both systolic BP (SBP: -8.7±1.7 versus -3.0±1.5; P=0.013) and diastolic BP (DBP: -5.1±0.98 versus -1.4±0.94 mm Hg; P<0.05), and the slope of the long-term pressure-natriuresis relationship affected significantly the presence of the lanosterol synthase rs2254524 A variant (AA: 0.71±0.22, AC 0.09±0.13, and CC 0.04±0.11 mEq/mm Hg/24 h; P=0.028). In addition, BP rose in ≈25% of the patients in response to the low salt diet and this was associated with increased circulating EO. Lanosterol synthase gene polymorphisms influence both the salt sensitivity of BP and changes in circulating EO in response to a low salt diet. The response of BP and EO to the low salt diet is markedly heterogeneous. Approximately 25% of patients experienced adverse effects, that is, increased BP and EO when salt intake was reduced and may be at increased long-term risk. The augmented response of EO to the low salt diet further supports the view that adrenocortical function is abnormal in some essential hypertensives.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Na-K ATPase; diet; digitalis-like factors; genetic polymorphisms; hypertension

Mesh:

Substances:

Year:  2015        PMID: 26667413      PMCID: PMC4713326          DOI: 10.1161/HYPERTENSIONAHA.115.06415

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Response to "Salt: the dying echoes of the food industry".

Authors:  David A McCarron; Alexandra G Kazaks; Joel C Geerling; Judith S Stern; Niels A Graudal
Journal:  Am J Hypertens       Date:  2013-12-19       Impact factor: 2.689

2.  Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes.

Authors:  Jae Wook Lee; Chung-Lin Chou; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 10.121

3.  Plasma digitalis-like factor(s) increase with salt loading.

Authors:  M H Gault; S C Vasdev; L L Longerich; P Fernandez; V Prabhakaran; M Dawe; C Maillet
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

4.  Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension.

Authors:  J C Roos; P Boer; H A Koomans; G G Geyskes; E J Dorhout Mees
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Urinary sodium and potassium excretion, mortality, and cardiovascular events.

Authors:  Martin O'Donnell; Andrew Mente; Sumathy Rangarajan; Matthew J McQueen; Xingyu Wang; Lisheng Liu; Hou Yan; Shun Fu Lee; Prem Mony; Anitha Devanath; Annika Rosengren; Patricio Lopez-Jaramillo; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Khalid Yusoff; Romaina Iqbal; Rafal Ilow; Noushin Mohammadifard; Sadi Gulec; Afzal Hussein Yusufali; Lanthe Kruger; Rita Yusuf; Jephat Chifamba; Conrad Kabali; Gilles Dagenais; Scott A Lear; Koon Teo; Salim Yusuf
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

6.  Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

Authors:  P Manunta; E Messaggio; C Ballabeni; M T Sciarrone; C Lanzani; M Ferrandi; J M Hamlyn; D Cusi; F Galletti; G Bianchi
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

7.  Salt, endogenous ouabain and blood pressure interactions in the general population.

Authors:  Ji-Guang Wang; Jan A Staessen; Elisabetta Messaggio; Tim Nawrot; Robert Fagard; John M Hamlyn; Giuseppe Bianchi; Paolo Manunta
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

Review 8.  Current salt reduction policies across gradients of inequality-adjusted human development in the WHO European region: minding the gaps.

Authors:  Rodrigo Rodriguez-Fernandez; Margarida Siopa; Sarah J Simpson; Rachel M Amiya; Joao Breda; Francesco P Cappuccio
Journal:  Public Health Nutr       Date:  2013-08-08       Impact factor: 4.022

9.  Proposed nomenclature for salt intake and for reductions in dietary salt.

Authors:  Norm R C Campbell; Ricardo Correa-Rotter; Francesco P Cappuccio; Jacqui Webster; Daniel T Lackland; Bruce Neal; Graham A MacGregor
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-21       Impact factor: 3.738

10.  Neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin II: a new axis in long term blood pressure control.

Authors:  John M Hamlyn; Cristina I Linde; Junjie Gao; Bing S Huang; Vera A Golovina; Mordecai P Blaustein; Frans H H Leenen
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

View more
  4 in total

1.  Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats.

Authors:  Jiao Lu; Hong-Wei Wang; Monir Ahmad; Marzieh Keshtkar-Jahromi; Mordecai P Blaustein; John M Hamlyn; Frans H H Leenen
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

2.  Genetics of ion homeostasis in Ménière's Disease.

Authors:  Roberto Teggi; Laura Zagato; Simona Delli Carpini; Lorena Citterio; Claudia Cassandro; Roberto Albera; Wen-Yi Yang; Jan A Staessen; Mario Bussi; Paolo Manunta; Chiara Lanzani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-11       Impact factor: 2.503

Review 3.  Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension.

Authors:  Rossella Iatrino; Paolo Manunta; Laura Zagato
Journal:  Curr Hypertens Rep       Date:  2016-09       Impact factor: 5.369

Review 4.  Endogenous cardiotonic steroids and cardiovascular disease, where to next?

Authors:  Davor Pavlovic
Journal:  Cell Calcium       Date:  2019-12-27       Impact factor: 6.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.